Q1 2026 · 13F-HR
DAFNA Capital Management LLCholdings as filed
Filed 2026-05-15 · accession 0001389933-26-000004
$439.6M
Reported value
83
Positions
2026-03-31
Period end
The Brief · DAFNA Capital Management LLC · Q1 2026
AI · grounded in 13F
DAFNA Capital Management LLC closed its position in Astria Therapeutics Inc CATBUSD, reducing its exposure by $3,989,505. The fund increased its stake in Compass Pathways PLC CMPS by 198.24% and Nektar Therapeutics NKTR by 120.24%. Additionally, the fund trimmed its holdings in Axogen Inc AXGN by 47.58% and Cytokinetics Inc CYTK by 41.38%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $56.5M | 12.8% | 580,678 | Common | SOLE |
| 78464A870 | XBI | SPDR S&P BIOTECH ETF | $40.7M | 9.25% | 318,505 | Common | SOLE |
| 85916J409 | STXS | STEREOTAXIS INC | $25.2M | 5.73% | 13,680,554 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $21.0M | 4.77% | 978,463 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $17.0M | 3.88% | 597,431 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $15.9M | 3.61% | 476,740 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $14.6M | 3.32% | 250,772 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $14.3M | 3.26% | 217,497 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $13.4M | 3.04% | 2,418,882 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $11.9M | 2.70% | 165,178 | Common | SOLE |
| 464287556 | IBB | ISHARES NASDAQ BIOTECH INDX | $10.5M | 2.39% | 62,095 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $9.6M | 2.18% | 443,829 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $9.3M | 2.12% | 70,615 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $9.1M | 2.08% | 2,029,164 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $8.4M | 1.91% | 421,733 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $8.3M | 1.88% | 249,960 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $7.2M | 1.63% | 845,735 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $6.8M | 1.55% | 355,208 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $6.1M | 1.39% | 318,500 | Common | SOLE |
| 04351PAD3 | ASND 2.25 04/01/28 | ASCENDIS PHARMA A/S | $5.9M | 1.35% | 4,000,000 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $5.5M | 1.25% | 2,434,353 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $5.4M | 1.23% | 86,279 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $5.4M | 1.22% | 267,402 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $5.3M | 1.21% | 23,177 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $5.2M | 1.19% | 175,465 | Common | SOLE |
| 45780L104 | INGN | INOGEN INC | $5.2M | 1.19% | 845,179 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $5.1M | 1.16% | 217,355 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $4.9M | 1.12% | 139,482 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $4.3M | 0.97% | 130,875 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $4.1M | 0.93% | 430,248 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $3.9M | 0.89% | 130,175 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $3.7M | 0.85% | 150,524 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $3.5M | 0.80% | 112,236 | Common | SOLE |
| 56565P103 | MPLT | MAPLIGHT THERAPEUTICS INC | $3.5M | 0.79% | 171,006 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $3.3M | 0.76% | 1,370,118 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $3.0M | 0.68% | 120,000 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $2.6M | 0.58% | 15,000 | Common | SOLE |
| N71542109 | PRQR | PROQR THERAPEUTICS N V | $2.5M | 0.58% | 1,567,561 | Common | SOLE |
| 23256X407 | HELP | CYBIN INC | $2.4M | 0.54% | 498,361 | Common | SOLE |
| 75383L102 | RAPP | RAPPORT THERAPEUTICS INC | $2.3M | 0.53% | 75,000 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $2.3M | 0.52% | 10,870 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $2.2M | 0.51% | 46,500 | Common | SOLE |
| N44445109 | IMTX | IMMATICS NV | $2.2M | 0.51% | 225,860 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC | $2.2M | 0.49% | 68,518 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $2.2M | 0.49% | 377,059 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $2.0M | 0.44% | 908,351 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $1.9M | 0.44% | 59,516 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $1.9M | 0.44% | 235,868 | Common | SOLE |
| 74319B502 | PROF | PROFOUND MEDICAL CORP | $1.7M | 0.39% | 263,005 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $1.6M | 0.36% | 205,000 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $1.5M | 0.35% | 368,415 | Common | SOLE |
| M68830112 | MDWD | MEDIWOUND LTD | $1.5M | 0.35% | 94,405 | Common | SOLE |
| 68752L100 | KIDS | ORTHOPEDIATRICS CORP | $1.5M | 0.35% | 95,659 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL INC | $1.3M | 0.29% | 61,100 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $1.3M | 0.29% | 187,353 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $1.1M | 0.26% | 56,635 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $1.1M | 0.25% | 139,285 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $1.1M | 0.25% | 230,000 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $1.0M | 0.24% | 35,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $1.0M | 0.24% | 38,490 | Common | SOLE |
| 811292200 | SCYX | SCYNEXIS INC | $996,630 | 0.23% | 1,086,956 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $945,460 | 0.22% | 98,724 | Common | SOLE |
| 457730109 | INSP | INSPIRE MEDICAL SYSTEMS INC | $938,756 | 0.21% | 18,200 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $910,602 | 0.21% | 207,900 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $893,438 | 0.20% | 1,441,029 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $830,875 | 0.19% | 42,500 | Common | SOLE |
| 92511W207 | VRCA | VERRICA PHARMACEUTICALS INC | $813,136 | 0.18% | 153,712 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $660,000 | 0.15% | 550,000 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $652,678 | 0.15% | 117,812 | Common | SOLE |
| 004397105 | ARAY | ACCURAY INC | $652,205 | 0.15% | 1,680,508 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA CO | $640,200 | 0.15% | 20,000 | Common | SOLE |
| 007002207 | ACET | ADICET BIO INC | $638,860 | 0.15% | 93,812 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $622,160 | 0.14% | 7,000 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $613,620 | 0.14% | 487,000 | Common | SOLE |
| M25722105 | CGEN | COMPUGEN LTD | $549,078 | 0.12% | 257,783 | Common | SOLE |
| 68572M106 | OBIO | ORCHESTRA BIOMED HOLDINGS INC | $539,074 | 0.12% | 126,841 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $534,686 | 0.12% | 111,859 | Common | SOLE |
| 451033708 | IBIO | IBIO INC | $367,912 | 0.08% | 193,638 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $299,243 | 0.07% | 64,492 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $270,304 | 0.06% | 72,081 | Common | SOLE |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $255,106 | 0.06% | 45,800 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS LTD | $247,456 | 0.06% | 179,316 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC | $136,500 | 0.03% | 70,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.